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at CuB in the O-state, or an additional hydroxyl group at Fea3.
However, the electron densities of all high resolution structures are
compatible best with a peroxo-bridge between Fea3 and CuB. In
addition, we ﬁnd that the F-state generated in the traditional way
by an excess of H2O2, can be converted into a P-state simply by
addition of catalase. Finally we have discovered conditions under
which the O-state spontaneously converts into a P-state with
concomitant formation of a tyrosine radical. All these results can be
understood best if the catalytic cycle starts with an O-state
containing a bridging peroxide dianion and the F-state contains a
superoxide bound to CuB.
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The cytochrome c oxidases (CcO), which are responsible for most
of the O2 consumption in biology, are also redox-linked proton
pumps that effectively convert the free energy of O2 reduction to an
electrochemical proton gradient across mitochondrial and bacterial
membranes. Recently, time-resolved measurements have elucidated
the sequence of events in proton translocation, and shed light on
the underlying molecular mechanisms. One crucial property of the
proton pump mechanism has received less attention, viz. how
proton leaks are avoided. Here, we will analyse this topic and
demonstrate how the key proton-carrying residue Glu-242 (num-
bering according to the sequence of subunit I of bovine heart CcO)
functions as a valve that has the effect of minimising back-leakage
of the pumped proton.
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All known proton pumping respiratory oxidases are members of
the heme-copper superfamily. This superfamily contains not only
the oxygen reductases (respiratory oxidases) but also prokaryotic
NO reductases that are used for denitriﬁcation and detoxiﬁcation.
Our work has focused on the largest group of respiratory oxidases,
the A-family, with the aim being to understand how the chemistry
of reducing oxygen to water is coupled to driving a unidirectional
proton pump. Most studies have used the aa3-type oxidase from R.
sphaeroides. Mutations in one of the two proton input channels, the
D channel, can decouple the proton pump from the redox
chemistry. The properties of these mutants will be discussed.
Recent studies have included respiratory oxidases that are not
members of the major (canonical) family of heme-copper oxidases,
but are in the B- and C-families. This includes work on the ba3-
type oxidase from Thermus thermophilus, in a collaboration with
the group of Dr. James Fee (Scripps Institute). Results will be
discussed.
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In cellular respiration, the mobile electron carrier cytochrome c
shuttles electrons from cytochrome bc1 complex to cytochrome c
oxidase. The X-ray structure of the complex between cytochrome c
and cytochrome bc1 complex at 2.97-Å resolution gave the ﬁrst
structural insight for such a complex from the respiratory chain.
The structure revealed the general features of the interface, which
is well suited for transient interaction and fast turnover. Remark-
ably, cytochrome c binds to only one recognition site of the
homodimeric complex. We now determined the structure of the
electron transfer complex in the reduced state at 1.9-Å resolution.
The high resolution allows an accurate description of the interface,
especially of electrostatic and water-mediated interactions. The
dimer structure is asymmetric. Monovalent cytochrome c binding
is correlated with conformational changes of the Rieske head
domain and subunit QCR6p and with a higher number of
interfacial water molecules bound to cytochrome c1. Comparison
with a second structure obtained for isoform-2 cytochrome c
bound to the cytochrome bc1 complex led to the deﬁnition of a
minimal interface, the so-called core interface, which is present in
all of these structures. The importance of single core interface
residues for formation of the reactive complex in solution was
probed by site-directed mutagenesis and characterization of the
variants.
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Ullrich Congenital Muscular Dystrophy (UCMD) and Bethlem
Myopathy (BM) are muscle diseases due to mutations in the genes
encoding the extracellular matrix protein collagen VI. Generation of a
dystrophic mouse model where collagen VI synthesis was prevented
by genetic ablation of the Col6a1 gene allowed an investigation of
pathogenesis, which revealed the existence of a Ca2+-mediated
dysfunction of mitochondria and the sarcoplasmic reticulum. A key
event appears to be inappropriate opening of the mitochondrial
permeability transition pore, an inner membrane high-conductance
channel. Consistently, the Col6a1−/− myopathic mice could be cured
with cyclosporin A through inhibition of cyclophilin D, a matrix
protein that sensitizes the pore to opening. Studies of myoblasts from
UCMD and BM patients demonstrated the existence of a latent
mitochondrial dysfunction irrespective of the genetic lesion respon-
sible for the lack or the alteration of collagen VI. These studies suggest
that PTP opening may represent the ﬁnal common pathway for
skeletal muscle ﬁber death; and provided a rationale for a pilot clinical
trial with cyclosporin A in patients affected by UCMD and BM. Prior to
treatment, all patients displayed mitochondrial dysfunction and
increased frequency of apoptosis, as determined in muscle biopsies.
Both these pathological signs were largely normalized after 1 month
of oral cyclosporin A administration, which also increased muscle
regeneration. These results indicate that mitochondrial dysfunction
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